-
1
-
-
38549154613
-
Photodistribution of blue-gray hyperpigmentation after amiodarone treatment: Molecular characterization of amiodarone in the skin
-
A. Ammoury, S. Michaud, C. Paul, C. Prost-Squarcioni, F. Alvarez, and L. Lamant Photodistribution of blue-gray hyperpigmentation after amiodarone treatment: Molecular characterization of amiodarone in the skin Archives of Dermatology 144 2008 92 96
-
(2008)
Archives of Dermatology
, vol.144
, pp. 92-96
-
-
Ammoury, A.1
Michaud, S.2
Paul, C.3
Prost-Squarcioni, C.4
Alvarez, F.5
Lamant, L.6
-
2
-
-
77953285216
-
Vacuolar ATPase-mediated sequestration of local anesthetics in swollen macroautophagosomes
-
M.T. Bawolak, G. Morissette, and F. Marceau Vacuolar ATPase-mediated sequestration of local anesthetics in swollen macroautophagosomes Canadian Journal of Anesthesia 57 2010 230 239
-
(2010)
Canadian Journal of Anesthesia
, vol.57
, pp. 230-239
-
-
Bawolak, M.T.1
Morissette, G.2
Marceau, F.3
-
3
-
-
80052875313
-
Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: Possible implications of lysosomal dysfunction in macular degeneration
-
P.M. Chen, Z.J. Gombart, and J.W. Chen Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: Possible implications of lysosomal dysfunction in macular degeneration Cell & Bioscience 1 2011 10
-
(2011)
Cell & Bioscience
, vol.1
, pp. 10
-
-
Chen, P.M.1
Gombart, Z.J.2
Chen, J.W.3
-
4
-
-
0016260069
-
Lysosomotropic agents
-
C. De Duve, T. de Barsy, B. Poole, A. Trouet, P. Tulkens, and F. Van Hoof Lysosomotropic agents Biochemical Pharmacology 23 1974 2495 2531
-
(1974)
Biochemical Pharmacology
, vol.23
, pp. 2495-2531
-
-
De Duve, C.1
De Barsy, T.2
Poole, B.3
Trouet, A.4
Tulkens, P.5
Van Hoof, F.6
-
5
-
-
0027656390
-
Quinacrine: Spectroscopic properties and interactions with polynucleotides
-
S.M. Doglia, B. Albinson, C. Hiort, B. Nordén, and A. Grässlund Quinacrine: Spectroscopic properties and interactions with polynucleotides Biopolymers 33 1993 1431 1442
-
(1993)
Biopolymers
, vol.33
, pp. 1431-1442
-
-
Doglia, S.M.1
Albinson, B.2
Hiort, C.3
Nordén, B.4
Grässlund, A.5
-
6
-
-
11144358446
-
Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier
-
S. Dohgu, A. Yamauchi, F. Takata, Y. Sawada, S. Higuchi, and M. Naito Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier Cellular and Molecular Neurobiology 24 2004 205 217
-
(2004)
Cellular and Molecular Neurobiology
, vol.24
, pp. 205-217
-
-
Dohgu, S.1
Yamauchi, A.2
Takata, F.3
Sawada, Y.4
Higuchi, S.5
Naito, M.6
-
7
-
-
79955799029
-
Beyond DNA binding - A review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers
-
R. Ehsanian, C. Van Waes, and S.M. Feller Beyond DNA binding - A review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers Cell Communication and Signaling 9 2011 13
-
(2011)
Cell Communication and Signaling
, vol.9
, pp. 13
-
-
Ehsanian, R.1
Van Waes, C.2
Feller, S.M.3
-
8
-
-
80051734288
-
Curaxins: Anti-cancer compounds that simultaneously suppress NK-κB and activate p53 by targeting FACT
-
A.V. Gasparia, C.A. Burkart, A.A. Purmal, L. Brodsky, M. Pal, and M. Saranadasa Curaxins: Anti-cancer compounds that simultaneously suppress NK-κB and activate p53 by targeting FACT Science Translational Medicine 3 2011 95ra74
-
(2011)
Science Translational Medicine
, vol.3
-
-
Gasparia, A.V.1
Burkart, C.A.2
Purmal, A.A.3
Brodsky, L.4
Pal, M.5
Saranadasa, M.6
-
9
-
-
33745234824
-
Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein
-
Y. Huang, H. Okochi, B.C. May, G. Legname, S.B. Prusiner, and L.Z. Benet Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein Drug Metabolism and Disposition 34 2006 1136 1144
-
(2006)
Drug Metabolism and Disposition
, vol.34
, pp. 1136-1144
-
-
Huang, Y.1
Okochi, H.2
May, B.C.3
Legname, G.4
Prusiner, S.B.5
Benet, L.Z.6
-
10
-
-
34247490248
-
Lysosomal sequestration of amine-containing drugs: Analysis and therapeutic implications
-
A.M. Kaufmann, and J.P. Krise Lysosomal sequestration of amine-containing drugs: Analysis and therapeutic implications Journal of Pharmaceutical Sciences 96 2007 729 746
-
(2007)
Journal of Pharmaceutical Sciences
, vol.96
, pp. 729-746
-
-
Kaufmann, A.M.1
Krise, J.P.2
-
11
-
-
84874688353
-
The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: What we (need to) know and how we can do so
-
D.B. Kell, P.D. Dobson, E. Bilsland, and S.G. Oliver The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: What we (need to) know and how we can do so Drug Discovery Today 18 2013 218 239
-
(2013)
Drug Discovery Today
, vol.18
, pp. 218-239
-
-
Kell, D.B.1
Dobson, P.D.2
Bilsland, E.3
Oliver, S.G.4
-
12
-
-
71049122853
-
Vacuolar ATPase-mediated cellular concentration and retention of quinacrine: A model for the distribution of lipophilic cationic drugs to autophagic vacuoles
-
F. Marceau, M.-T. Bawolak, J. Bouthillier, and G. Morissette Vacuolar ATPase-mediated cellular concentration and retention of quinacrine: A model for the distribution of lipophilic cationic drugs to autophagic vacuoles Drug Metabolism and Disposition 37 2009 2271 2274
-
(2009)
Drug Metabolism and Disposition
, vol.37
, pp. 2271-2274
-
-
Marceau, F.1
Bawolak, M.-T.2
Bouthillier, J.3
Morissette, G.4
-
13
-
-
84857111835
-
Cation trapping by cellular acidic compartments: Beyond the concept of lysosomotropic drugs
-
F. Marceau, M.-T. Bawolak, R. Lodge, J. Bouthillier, A. Gagné-Henley, and R.C. Gaudreault Cation trapping by cellular acidic compartments: Beyond the concept of lysosomotropic drugs Toxicology and Applied Pharmacology 259 2012 1 12
-
(2012)
Toxicology and Applied Pharmacology
, vol.259
, pp. 1-12
-
-
Marceau, F.1
Bawolak, M.-T.2
Lodge, R.3
Bouthillier, J.4
Gagné-Henley, A.5
Gaudreault, R.C.6
-
14
-
-
0021953169
-
In vitro induction of cytologic and functional differentiation of the immature human monocyte-like cell line U-937 with phorbol myristate acetate
-
J.O. Minta, and L. Pambrun In vitro induction of cytologic and functional differentiation of the immature human monocyte-like cell line U-937 with phorbol myristate acetate American Journal of Pathology 119 1985 111 126
-
(1985)
American Journal of Pathology
, vol.119
, pp. 111-126
-
-
Minta, J.O.1
Pambrun, L.2
-
15
-
-
41949116716
-
Intense pseudotransport of a cationic drug mediated by vacuolar ATPase: Procainamide-induced autophagic cell vacuolization
-
G. Morissette, R. Lodge, and F. Marceau Intense pseudotransport of a cationic drug mediated by vacuolar ATPase: Procainamide-induced autophagic cell vacuolization Toxicology and Applied Pharmacology 228 2008 364 377
-
(2008)
Toxicology and Applied Pharmacology
, vol.228
, pp. 364-377
-
-
Morissette, G.1
Lodge, R.2
Marceau, F.3
-
17
-
-
84878178282
-
High affinity capture and concentration of quinacrine in polymormonuclear neutrophil via vacuolar ATPase-mediated ion trapping: Comparison with other peripheral blood leukocytes and implications for the distribution of cationic drugs
-
C. Roy, V. Gagné, M.J.G. Fernandes, and F. Marceau High affinity capture and concentration of quinacrine in polymormonuclear neutrophil via vacuolar ATPase-mediated ion trapping: Comparison with other peripheral blood leukocytes and implications for the distribution of cationic drugs Toxicology and Applied Pharmacology 270 2013 77 86
-
(2013)
Toxicology and Applied Pharmacology
, vol.270
, pp. 77-86
-
-
Roy, C.1
Gagné, V.2
Fernandes, M.J.G.3
Marceau, F.4
|